Iranian Journal of Pediatrics
Tehran University of Medical Sciences Press
Vol. 18, No. s1, 2008, pp. 15-20
Bioline Code: pe08065
Full paper language: Farsi
Document type: Research Article
Document available free of charge
Iranian Journal of Pediatrics, Vol. 18, No. s1, 2008, pp. 15-20
© Copyright 2008 - TUMS PUBLICATIONS
The Effect of Baclofen on Treatment of Infancy Gastro-esophageal Reflux Disorder|
Khodadad, Ahmad; Sani, Mehri Najafi; Nemat-Khorasani, Enayatollah & Mansouri, Fariba
Transient lower esophageal sphincter relaxation (TLESR) is the major cause of gastroesophageal
reflux disorder (GERD) in patient with reflux disease. GERD is the most common
esophageal disorder in children. The GABA agonist baclofen decreases acid reflux through the
inhibition of TLESRs and should similarly decrease non-acid reflux. The aim of this study was to
evaluate the effect of baclofen on GERD in children.
Thirty children with GERD were included in this clinical trial. Baclofen 0.25 mg/kg was
given for three months. End points were assessed for weeks and months.
Baclofen significantly improved the weight gain pattern and the mean of weight gain
demonstrated a significant difference between base line value and weight on consequent months
after therapy (P<0.0001). Restlessness showed a significant improvement between baseline and
threes month after treatment (P<0.001).Vomiting significantly decreased on follow up visits
(P<0.001). It is also increased the time and volume of feeding significantly 3 month after treatment
(P<0.001). We have not found serious complications.
Baclofen reduces the symptom of TLESRs and may have a role in treating GERD.
GERD; Vomiting; Baclofen; Esophageal sphincter relaxation; Reflux
Alternative site location: http://diglib.tums.ac.ir/pub/